MX2022004744A - Compositions comprising 2'-fucosyllactose to prevent asthma. - Google Patents

Compositions comprising 2'-fucosyllactose to prevent asthma.

Info

Publication number
MX2022004744A
MX2022004744A MX2022004744A MX2022004744A MX2022004744A MX 2022004744 A MX2022004744 A MX 2022004744A MX 2022004744 A MX2022004744 A MX 2022004744A MX 2022004744 A MX2022004744 A MX 2022004744A MX 2022004744 A MX2022004744 A MX 2022004744A
Authority
MX
Mexico
Prior art keywords
fucosyllactose
compositions
prevent asthma
asthma
prevent
Prior art date
Application number
MX2022004744A
Other languages
Spanish (es)
Inventor
Arjen Nauta
Dirk Andries Groeneveld
Original Assignee
Frieslandcampina Nederland Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frieslandcampina Nederland Bv filed Critical Frieslandcampina Nederland Bv
Publication of MX2022004744A publication Critical patent/MX2022004744A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A composition comprising 2'-fucosyllactose (2'-FL) for use in the prevention of asthma in a human subject by administering the composition to the mother while being pregnant with the subject.
MX2022004744A 2019-10-24 2020-10-23 Compositions comprising 2'-fucosyllactose to prevent asthma. MX2022004744A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19205076 2019-10-24
PCT/EP2020/079849 WO2021078920A1 (en) 2019-10-24 2020-10-23 Compositions comprising 2'-fucosyllactose to prevent asthma

Publications (1)

Publication Number Publication Date
MX2022004744A true MX2022004744A (en) 2022-05-16

Family

ID=68342790

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022004744A MX2022004744A (en) 2019-10-24 2020-10-23 Compositions comprising 2'-fucosyllactose to prevent asthma.

Country Status (5)

Country Link
EP (1) EP4048283A1 (en)
CN (1) CN114599232A (en)
MX (1) MX2022004744A (en)
TW (1) TW202128190A (en)
WO (1) WO2021078920A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113796546A (en) * 2021-09-13 2021-12-17 合生元（广州）健康产品有限公司 Breast milk oligosaccharide composition for improving intestinal barrier function and application thereof
WO2023122270A2 (en) * 2021-12-23 2023-06-29 Amyris, Inc. Compositions and methods for improved production of human milk oligosaccharides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1993577B1 (en) * 2006-03-10 2014-02-12 N.V. Nutricia Use of non-digestable sacharides for giving an infant the best start after birth
US8197872B2 (en) 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
WO2011008086A1 (en) * 2009-07-15 2011-01-20 N.V. Nutricia Mixture of non-digestible oligosaccharides for stimulating the immune system
EP2675899A4 (en) 2011-02-16 2014-09-10 Glycosyn LLC Biosynthesis of human milk oligosaccharides in engineered bacteria
RU2697650C1 (en) * 2013-11-15 2019-08-16 Сосьете Де Продюи Нестле С.А. Compositions for preventing or treating allergies in infants born or fed by non-secretory mothers by providing fucosylated oligosaccharides, particularly infants at risk of or born by cesarean section
WO2016029113A1 (en) * 2014-08-22 2016-02-25 Abbott Laboratories Methods of increasing endogenous production of beta-hydroxy-beta-methylbutyrate
WO2017078519A1 (en) 2015-11-04 2017-05-11 Koninklijke Coöperatie Cosun U.A. High dietary fiber cereal bars
US11512299B2 (en) 2015-12-29 2022-11-29 Amano Enzyme Inc. Beta-galactosidase enzymes
CN108471793A (en) * 2016-01-26 2018-08-31 雀巢产品技术援助有限公司 For baby or child to prevent or treat the composition for including human milk oligosaccharides of allergy
CN110799195B (en) 2017-06-28 2023-09-15 菲仕兰坎皮纳荷兰公司 Method for preparing GOS with reduced allergenicity

Also Published As

Publication number Publication date
EP4048283A1 (en) 2022-08-31
TW202128190A (en) 2021-08-01
CN114599232A (en) 2022-06-07
WO2021078920A1 (en) 2021-04-29

Similar Documents

Publication Publication Date Title
MX2019015580A (en) Methods for treating huntington's disease.
MX2020009957A (en) Compounds for treating huntington's disease.
MX2019015578A (en) Methods for treating huntington's disease.
ZA202110659B (en) Methods of reducing the risk of cardiovascular events in a subject
MX2022006107A (en) Methods and compositions for dosing in adoptive cell therapy.
NZ700881A (en) Compositions and methods comprising celecoxib or related compounds and dextromethorphan
MX2015004565A (en) Laquinimod for reducing thalamic damage in multiple sclerosis.
EA201690107A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMATE FOR INTRODUCTION TO LOW DAILY DOSE
MX2021013854A (en) Compounds for treating huntington's disease.
EP2512479A4 (en) Methods and compositions for treating peripheral vascular disease
MX2022004744A (en) Compositions comprising 2'-fucosyllactose to prevent asthma.
SG10201810404XA (en) Combination comprising a glucocorticoid and edo-s101
WO2014058979A3 (en) Laquinimod for reducing thalamic damage in multiple sclerosis
WO2018111315A8 (en) PYRIMIDINE TRICYCLIC ENONE DERIVATIVES FOR INHIBITION OF RORγ AND OTHER USES
NZ714273A (en) Pharmaceutical composition comprising the combination of a biocompatible nanoparticle and a compound of interest, preparation and uses thereof
IN2014DN08582A (en)
MX2017006813A (en) Pharmaceutical composition, preparation and uses thereof.
MX2018008694A (en) Methods and compositions for treating hyperhidrosis.
MX2021010595A (en) Pharmaceutical composition, preparation and uses thereof.
MX2019002284A (en) Depot systems comprising glatiramer acetate.
SG10201907291QA (en) Monomethylfumarate prodrug compositions
MY193963A (en) Composition for treating joint diseases and kit containing same
MX2019012522A (en) Therapeutic compounds and methods.
MX2015010594A (en) Lipobalanced long chain testosterone esters for oral delivery.
MX2021015732A (en) Intranasal administration of merotocin for improving lactation.